These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 6391673)
41. The effect of small doses of guanfacine (Estulic Sandoz) on the lipid levels and catecholamine excretion in patients with essential hypertension. Balazovjech I; Skultétyová D; Mikulecký M; Kratochvíl'ová H Cor Vasa; 1987; 29(4 Suppl 1):46-52. PubMed ID: 3315451 [TBL] [Abstract][Full Text] [Related]
42. A new centrally action antihypertensive agent guanfacine (BS 100-141). Dubach UC; Huwyler R; Radielovic P; Singeisen M Arzneimittelforschung; 1977; 27(3):674-6. PubMed ID: 326262 [TBL] [Abstract][Full Text] [Related]
43. [First experiences with BS 100-141, a new antihypertensive substance]. Esch I Int J Clin Pharmacol Biopharm; 1976 Sep; 14(2):109-12. PubMed ID: 793999 [TBL] [Abstract][Full Text] [Related]
44. [Estulic in the long-term treatment of hypertension]. Rhomberg F Schweiz Med Wochenschr; 1980 Dec; 110(50):1922-4. PubMed ID: 6782668 [TBL] [Abstract][Full Text] [Related]
45. Long-term efficacy and tolerance of the antihypertensive agent guanfacine. Jerie P; Lasance A Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):170-4. PubMed ID: 6370876 [TBL] [Abstract][Full Text] [Related]
46. [Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)]. Rosenthal J; Schäfer N; Rauh J; Raschig A Dtsch Med Wochenschr; 1980 Nov; 105(48):1680-4. PubMed ID: 7002524 [TBL] [Abstract][Full Text] [Related]
47. [Guanfacine in primary arterial hypertension: a long-term open clinical study]. Román O; Valenzuela MA; Salazar R Rev Med Chil; 1982 Dec; 110(12):1179-84. PubMed ID: 6764015 [No Abstract] [Full Text] [Related]
48. Hypotensive effect of guanfacine in essential hypertension: a comparison with clonidine. Lauro R; Reda G; Spallone L; Anguissola AB Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):81S-82S. PubMed ID: 6994784 [No Abstract] [Full Text] [Related]
49. Antihypertensive treatment in mild hypertension, its problems and future trends. Widimský J Cor Vasa; 1987; 29(4 Suppl 1):1-10. PubMed ID: 3315445 [No Abstract] [Full Text] [Related]
50. [The place of guanfacine in the treatment of essential arterial hypertension]. Koaté P; Diouf S; Sylla M; Sarr M; Ba SA Dakar Med; 1983; 28(2):321-36. PubMed ID: 6360603 [No Abstract] [Full Text] [Related]
51. [Minimal useful dose of guanfacine in patients with essential hypertension]. Pérez Olea J; Ortíz N; Soledad Bertoló M; Allel L; Goity C; Quevedo M Rev Med Chil; 1985 May; 113(5):420-4. PubMed ID: 3912882 [No Abstract] [Full Text] [Related]
52. [Comparative study of the antihypertensive effect of guanfacine and guanethidine]. Kállay K; Szám I; Káldi N Orv Hetil; 1981 Jul; 122(29):1777-83. PubMed ID: 7027137 [No Abstract] [Full Text] [Related]
53. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)]. Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G Arzneimittelforschung; 1980; 30(6):1005-7. PubMed ID: 6998487 [TBL] [Abstract][Full Text] [Related]
54. Comparative study of two antihypertensive agents: guanfacine and guanethidine. Szám I; Kállay K Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786 [TBL] [Abstract][Full Text] [Related]
55. Experiences with guanfacine in a two-year follow-up study. Titscher G Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):83S-84S. PubMed ID: 6994785 [No Abstract] [Full Text] [Related]
56. Lifelong antihypertensive therapy. Klugman KP; Palmer J; Schultz E S Afr Med J; 1980 May; 57(21):851. PubMed ID: 6996131 [No Abstract] [Full Text] [Related]
57. [Guanfacine: controlled clinical study in arterial hypertension]. Lauro R Clin Ter; 1980 May; 93(4):439-55. PubMed ID: 6998644 [No Abstract] [Full Text] [Related]